General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study.
about
Radical prostatectomy versus watchful waiting for prostate cancerThe primary health care physician and the cancer patient: tips and strategies for managing sexual healthInsurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.Epidemiology of Functional abdominal bloating and its impact on health related quality of life: male-female stratified propensity score analysis in a population based survey in mainland China.Anatomical grades of nerve sparing: a risk-stratified approach to neural-hammock sparing during robot-assisted radical prostatectomy (RARP).Health-related quality of life and cancer clinical trials.Dyadic concordance among prostate cancer patients and their partners and health-related quality of life: does it matter?Proerectile pharmacological prophylaxis following nerve-sparing radical prostatectomy (NSRP).Health related quality of life for men treated for localized prostate cancer with long-term followupCurrent trends in the management of post-prostatectomy incontinence.Multilevel modeling in psychosomatic medicine research.Management of prostate cancer. Part 2: localized and locally advanced disease.Long-term quality of life after radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial.Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma.Reducing biochemical recurrence rates in EBRT-treated prostate cancer patients: the influence of dose and dose per fraction.Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification.Treatment regret and quality of life following radical prostatectomy.Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.Population-based cancer registries for quality-of-life research: a work-in-progress resource for survivorship studies?Psychosocial perspectives on sexual recovery after prostate cancer treatment.Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients.The impact of prostate cancer on men's everyday life.Nightly sildenafil use after radical prostatectomy has adverse effects on urinary convalescence: Results from a randomized trial of nightly vs on-demand dosing regimens.The effect of nerve-sparing surgery on patient-reported continence post-radical prostatectomy.A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer.The effect of urinary incontinence on health utility and health-related quality of life in men following prostate surgery.Identifying how and for whom cognitive-behavioral stress management improves emotional well-being among recent prostate cancer survivors.Quality of life in men receiving radiotherapy and neo-adjuvant androgen deprivation for prostate cancer: results from a prospective longitudinal study.A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.Clinically relevant fatigue in recurrence-free prostate cancer survivors.Overactive bladder syndrome: an underestimated long-term problem after treatment of patients with localized prostate cancer?Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.A longitudinal study of coping strategies in men receiving radiotherapy and neo-adjuvant androgen deprivation for prostate cancer: a quantitative and qualitative study.Reappraisal in the eighth life cycle stage: a theoretical psychoeducational intervention in elderly patients with cancer.A randomised, wait-list controlled trial: evaluation of a cognitive-behavioural group intervention on psycho-sexual adjustment for men with localised prostate cancer.The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors.
P2860
Q24236564-8B42A236-426C-43AB-A55E-2C607D9989D2Q26773683-660C17E4-05E5-4302-95A2-CBB37F153F7FQ31147370-5FC6FFDC-6C0F-4CB3-B122-054D4FAA568BQ33359279-05D448FA-4744-4996-9B10-5E5D4FB10007Q33921466-DCF3E8E8-392E-48B5-B56B-81744DE104F2Q34216284-0C64D14D-030C-41AF-9750-90CB63E44BD6Q35076356-E7F4B455-04AB-4613-B98A-EBF02EA14823Q35551231-2CAC53AB-2457-415E-9A2F-E672CD337E57Q35834297-FA9EDDBB-E132-4130-B641-F0483FC94D4EQ36075394-4C4D9F8B-08B8-4FCE-9D59-12E8CCA2CF5DQ36189747-9B20D22D-22AF-45FB-9135-B7323B8DDD82Q36400096-81779FED-8279-49A1-BE53-C0330458AC34Q36448693-CC5C95D0-6EB6-4C3D-9348-6BDBFE86168AQ36537801-B1B19AE5-EABC-4AD1-992D-7B78BB00CC00Q36553699-38D19275-BA3C-4642-8E18-B416DA42900EQ37016012-B046AAA1-D99F-4CE2-8748-2182F3885A07Q37074954-53A5E62F-9C67-40F4-BD70-3A14F4B6B411Q37297354-76854EF7-2FE3-4D37-AA1E-B6C6656276D8Q37444820-2459EC67-3FCA-478C-8B45-140FA0BC20F5Q38033742-B33D35F9-9902-4437-9DC2-259CF008C25EQ38108548-88CD0A32-04EA-454A-ABAE-82CD25115F92Q38370882-3DD3D422-48C3-4456-A9BA-0EE65BCC1A9FQ39167790-56F3C104-DCDC-4EF3-AA26-630F40F6E06AQ40162552-8093C930-493B-4DFE-A4BC-C60FFCC00DBCQ40221019-0F9EF25F-A6DF-4A1F-B08A-DBA269E6D311Q41808437-80D28268-3A4D-49D0-8169-6DF2DFD8F0D8Q42134022-E8C0FF84-9E95-46DC-A782-CB8AC74C05B9Q43648288-DEA792D7-3C2D-4749-9B5C-5802F776205EQ43983064-F691FEDC-B1FB-4269-A210-3BBC0C8FF5A5Q44307155-36187521-62E3-443A-B309-54B2F0064C60Q44463145-6AF44804-5EE8-4EFF-903B-080851FE2283Q44978278-83DCA983-4AB3-44D3-99CA-F6B95790ADB3Q45243762-48FD45E9-ADB3-4B58-B7D3-8135A68FC906Q45767001-A2E1941C-00C1-40E2-A7AA-4B6B949DA1B8Q46099719-31CC2AC2-68DB-4F54-8A4A-81A5910627E9Q46619020-68A7440E-C174-4D1A-83C5-9FDE19638C05Q46686756-7B8F4A19-57E6-4C21-B742-7C95DED19D18Q47628853-7AE048DD-558A-4F7C-B69A-947D05211B28Q48030884-72538963-8935-490A-B133-D5CD3025FF9BQ48072037-2571288F-AD44-4835-A714-C5D3F0DEEBFF
P2860
General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
General quality of life 2 year ...... rostate cancer outcomes study.
@en
type
label
General quality of life 2 year ...... rostate cancer outcomes study.
@en
prefLabel
General quality of life 2 year ...... rostate cancer outcomes study.
@en
P2093
P50
P356
P1476
General quality of life 2 year ...... rostate cancer outcomes study.
@en
P2093
Alan Kuniyuki
Arnold L Potosky
Dale McClerran
Frank Gilliland
Janet L Stanford
Peter C Albertsen
Robert A Stephenson
Ziding Feng
P304
P356
10.1200/JCO.2003.07.139
P407
P577
2003-03-01T00:00:00Z